Table 1 Clinical and demographic data of the studied group with respect to platelet aggregation assessed by MEA Multiplate analyzer at the cutoff point of 345 AUmin
| Â | ADPtest | ADPtest | P-value |
|---|---|---|---|
<345 AU × min | 345 ≥ AU × min | ||
n = 160 | n = 40 | ||
Age (years) (mean ± SD) | 66.5 ± 11.1 | 69.6 ± 10.8 | p = 0.084 |
Male (%) | 109 (68%) | 29 (72.5%) | p = 0.593 |
STEMI (%) | 74 (53%) | 20 (50%) | p = 0.695 |
ASPItest (AU x min) | 88.9 ± 73.0 | 173.1 ± 150.0 | p < 0.001 |
Drug eluting stent | 132 (94%) | 33 (83%) | p = 0.911 |
Stent diameter (mm) (median) | 3.0 | 3.0 | p = 0.450 |
Stent (s) length (mm) | 18.0 | 22.0 | p = 0.247 |
Inflation pressure (atm) (median) | 16.0 | 16.0 | p = 0.809 |
Fibrinogen (mg/dL) (mean ± SD) | 451 ± 133 | 480 ± 138 | p = 0.358 |
LDL (mmol/L) (mean ± SD) | 2.83 ± 1.1 | 2.58 ± 0.9 | p = 0.278 |
Creatinine (umol/L) (mean ± SD) | 92.9 ± 34.4 | 103.4 ± 67.6 | p = 0.421 |
hsCRP (mg/dL) (median) | 0.4 | 0.5 | p = 0.396 |
Platelet count (103/ml) (mean ± SD) | 204 ± 60 | 223 ± 70 | p = 0.117 |
White blood count (103/ml) (mean ± SD) | 8.65 | 8.45 | p = 0.793 |
Hemoglobin (mg/dL) (median) | 13.8 | 12.8 | p = 0.067 |
Insulin therapy | 46 (33%) | 15 (38%) | P = 0.293 |